New amino acid changes in drug resistance sites and HBsAg in hepatitis B virus genotype H

Journal of Medical Virology
D A Fernández-GalindoL V Sánchez-Orozco

Abstract

Long-term treatment with retrotranscriptase (RT) inhibitors eventually leads to the development of drug resistance. Drug-related mutations occur naturally and these can be found in hepatitis B virus (HBV) carriers who have never received antiviral therapy. HBsAg are overlapped with RT domain, thus nucleot(s)ide analogues (NAs) resistance mutations and naturally-occurring mutations can cause amino acid changes in the HBsAg. Twenty-two patients with chronic hepatitis B were enrolled; three of them were previously treated with NAs and 19 were NAs-naïve treated. HBV reverse transcriptase region was sequenced; genotyping and analysis of missense mutations were performed in both RT domain and HBsAg. There was predominance of genotype H. Drug mutations were present in 18.2% of patients. Classical lamivudine resistance mutations (rtM204V/rtL180M) were present in one naïve-treatment patient infected with genotype G. New amino acid changes were identified in drug resistance sites in HBV strains from patients infected with genotype H; rtQ215E was present in two naïve-NAs treatment patients and rtI169M was identified in a patient previously treated with lamivudine. Mutations at sites rt169, rt204, and rt215 resulted in the Y161C, I195M, an...Continue Reading

References

Jan 1, 1992·Intervirology·H J StirkC R Howard
Aug 11, 1990·Lancet·W F CarmanH C Thomas
Jan 30, 1997·The New England Journal of Medicine·J H Hoofnagle, A M di Bisceglie
Feb 12, 1998·The Journal of General Virology·H L ChiouM S Ho
Feb 5, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Tanja BauerWolfgang Jilg
Sep 5, 2002·Journal of Medical Virology·L V SánchezA Panduro
Sep 24, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Scott K Fung, Anna S F Lok
Oct 21, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Eishiro MizukoshiBarbara Rehermann
Oct 26, 2005·Journal of Hepatology·Patrick Marcellin, Tarik Asselah
Dec 13, 2005·Journal of Hepatology·Scott K FungAnna S F Lok
Jan 9, 2007·World Journal of Gastroenterology : WJG·Stephan Schaefer
Apr 6, 2007·Gastroenterology·Anna Suk-Fong Lok
Apr 6, 2007·Gastroenterology·Marc Ghany, T Jake Liang
Sep 20, 2007·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Tadasu Shin-IMasashi Mizokami
Feb 18, 2009·World Journal of Gastroenterology : WJG·Rebecca PastorEvelyne Schvoerer
Oct 15, 2010·Memórias do Instituto Oswaldo Cruz·Adriana Cristina da SilvaMaria Cássia Jacintho Mendes-Correa
May 28, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Chanunta HongthanakornAnna S F Lok
Jul 2, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ezequiel RidruejoMarcelo O Silva
Jan 1, 2014·World Journal of Gastroenterology : WJG·Il Han SongYoung Kwang Choo

❮ Previous
Next ❯

Citations

Dec 8, 2017·Journal of Immunology Research·Sina FeustelL V Sánchez-Orozco
Mar 20, 2018·Archives of Virology·David Esaú Fragoso-FonsecaJosé Ernesto Ramírez-González
Jul 3, 2021·Viruses·Marina Campos-ValdezLaura V Sánchez-Orozco

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.